comparemela.com

Latest Breaking News On - Novel platform - Page 2 : comparemela.com

SK Biopharmaceuticals Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPEDtm Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference

SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central nervous system (CNS) and oncology, and its U.S. R&D subsidiary, Proteovant Therapeutics, today announced.

Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform

Moving Past Animal Models with Better Data for Drug Discovery

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.